Merion Station, PA, United States of America

Robert H Vonderheide

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 407(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Robert H. Vonderheide

Introduction

Robert H. Vonderheide is an accomplished inventor based in Merion Station, Pennsylvania, known for his significant contributions to the field of immunology. With a portfolio of eight patents, Vonderheide has established himself as a pioneer in the development of novel therapeutics aimed at enhancing T cell expansion and activation.

Latest Patents

Vonderheide's latest patent, titled "Artificial antigen presenting cells and uses thereof," revolves around innovative artificial antigen presenting cells (aAPCs). These aAPCs include at least one stimulatory ligand and one co-stimulatory ligand, which are crucial for binding with specific molecules on targeted T cells. This mechanism facilitates the expansion of T cells, which is a vital aspect of developing effective cancer therapies and other immunological treatments. The aAPC technology can be utilized as an 'off the shelf' tool, allowing for easy design and implementation to meet specific therapeutic needs. Furthermore, this invention aims to identify various factors that contribute to T cell growth and expansion, offering promising avenues for future research and development.

Career Highlights

Robert H. Vonderheide holds a prominent position at the University of Pennsylvania, where he contributes to groundbreaking research in immunotherapy. His work has consistently focused on enhancing immune responses to combat diseases, particularly cancer. He has made notable strides in bridging laboratory research with clinical applications, helping to propel the field of immunology forward.

Collaborations

Throughout his career, Vonderheide has collaborated with notable professionals, including Carl H. June and James L. Riley. These partnerships have been instrumental in advancing research initiatives and combining expertise to foster innovation within the field of cancer treatment. Together, they have worked on projects that leverage cutting-edge science to improve patient outcomes and therapeutic strategies.

Conclusion

Robert H. Vonderheide’s contributions to science through his inventions and patents reflect his commitment to improving human health. As he continues to innovate at the University of Pennsylvania, his work in artificial antigen presenting cells paves the way for new therapeutic possibilities in immunology. Vonderheide represents the spirit of innovation that drives progress in the medical field, making him a significant figure among contemporary inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…